Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 181,661 | 125,276 | 116,129 | 113,892 | 115,791 |
| Operating Income | -181,661 | -125,276 | -116,129 | -113,892 | -115,791 |
| Interest Expense | 4,595 | 4,202 | 3,194 | 2,904 | 94 |
| Other Income | 7,700 | 8,624 | 7,368 | 8,755 | 5,028 |
| Pre-tax Income | -178,556 | -120,854 | -111,955 | -108,041 | -110,857 |
| Net Income Continuous | -178,556 | -120,854 | -111,955 | -108,041 | -110,857 |
| Net Income | $-178,556 | $-120,854 | $-111,955 | $-108,041 | $-110,857 |
| EPS Basic Total Ops | -1.08 | -0.73 | -0.69 | -0.76 | -0.97 |
| EPS Basic Continuous Ops | -1.08 | -0.73 | -0.69 | -0.76 | -0.97 |
| EPS Diluted Total Ops | -1.08 | -0.73 | -0.69 | -0.76 | -0.97 |
| EPS Diluted Continuous Ops | -1.08 | -0.73 | -0.69 | -0.76 | -0.97 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -0.73 | -0.76 | -0.76 | -0.97 |
| EBITDA(a) | $-181,334 | $-124,997 | $-115,996 | $-113,737 | $-115,751 |